adjuvant egfr tki therapy in patients with completely resected non-small-cell lung cancer: curren...
Published 3 months ago • 4 plays • Length 50:38Download video MP4
Download video MP3
Similar videos
-
59:19
precision oncology in early-stage lung cancer, with adjuvant egfr-targeted therapy leading the way
-
8:44
adjuvant egfr inhibition in patients with nsclc
-
2:33
adaura: osimertinib adjuvant therapy in egfr mutated nsclc
-
10:45
debate: adjuvant egfr-directed therapy for patients with early stage nsclc? - no
-
24:30
s1 episode 4: managing lung cancer with neoadjuvant and adjuvant therapy
-
4:38
egfr tkis as adjuvant therapy in nsclc
-
14:30
adjuvant therapy for egfr mutant nsclc
-
1:33
neoadjuvant egfr tki trials in nsclc
-
6:20
asco 2023 highlights on adjuvant osimertinib in resected egfr mutated nsclc: the adaura trial
-
5:03
adaura results: adjuvant osimertinib for egfrm non-small cell lung cancer
-
23:42
current status of adjuvant therapy for nsclc
-
1:02:05
adjuvant egfr-targeted therapy as a game changer in multimodal nsclc management
-
2:20
adjuvant osimertinib in resected egfrm nsclc: the os data from the adaura trial
-
7:28
asco: adjuvant osimertinib for resected egfr-positive non-small cell lung cancer
-
18:56
dr nandini menon first generation egfr tkis as adjuvant therapy in resected nsclc patients with sens
-
1:42
adaura: the benefit of adjuvant osimertinib
-
13:56
adjuvant therapy - chemotherapy issues
-
3:52
is adjuvant chemotherapy in egfr mutated nsclc still required?
-
3:41
egfr inhibitors as adjuvant therapy in nsclc